Case Control Study
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. May 15, 2024; 16(5): 1737-1744
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1737
Evaluation of the value of combined detection of tumor markers CA724, carcinoembryonic antigen, CA242, and CA19-9 in gastric cancer
Chong-Mei Zhou, Shao-Hua Zhao
Chong-Mei Zhou, Shao-Hua Zhao, Department of Clinical Laboratory, Henan Provincial People's Hospital, Zhengzhou 450003, Henan Province, China
Author contributions: Zhou CM designed the research study; Zhao SH performed the research; Zhou CM and Zhao SH contributed new reagents and analytical tools; Zhou CM analyzed the data and wrote the manuscript; all authors have read and approved the final version of the manuscript.
Institutional review board statement: The study was reviewed and approved by the Science and Research Office of Henan Provincial People’s Hospital (Henan).
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: There are no conflicts of interest to report.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Chong-Mei Zhou, Doctor, Master's Student, Department of Clinical Laboratory, Henan Provincial People’s Hospital, No. 38 Nongke Road, Jinshui District, Zhengzhou 450003, Henan Province, China. vlm010o@163.com
Received: January 12, 2024
Peer-review started: January 12, 2024
First decision: January 30, 2024
Revised: February 8, 2024
Accepted: March 20, 2024
Article in press: March 20, 2024
Published online: May 15, 2024
Processing time: 118 Days and 10.2 Hours
Core Tip

Core Tip: This study provides a theoretical basis for clinical screening programs for patients with gastric cancer. In the future, the combined detection of carbohydrate antigens (CA) 724, carcinoembryonic antigen, CA242, and CA19-9 could complement the clinical diagnosis.